BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1189 related articles for article (PubMed ID: 33953163)

  • 1. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer.
    Wu F; Fan J; He Y; Xiong A; Yu J; Li Y; Zhang Y; Zhao W; Zhou F; Li W; Zhang J; Zhang X; Qiao M; Gao G; Chen S; Chen X; Li X; Hou L; Wu C; Su C; Ren S; Odenthal M; Buettner R; Fang N; Zhou C
    Nat Commun; 2021 May; 12(1):2540. PubMed ID: 33953163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptome analysis reveals heterogeneity of neutrophils in non-small cell lung cancer.
    Wang Y; Zhu Z; Luo R; Chen W
    J Gene Med; 2024 May; 26(5):e3690. PubMed ID: 38735760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
    Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
    RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
    Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
    Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment.
    Zhang J; Song C; Tian Y; Yang X
    Front Immunol; 2021; 12():802080. PubMed ID: 35126365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and senescence characteristics associated with the immune microenvironment in non-small cell lung cancer: insights from single-cell RNA sequencing.
    Liao H; Wan Z; Liang Y; Kang L; Wan R
    Aging (Albany NY); 2023 Oct; 15(20):11571-11587. PubMed ID: 37889543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer.
    De Zuani M; Xue H; Park JS; Dentro SC; Seferbekova Z; Tessier J; Curras-Alonso S; Hadjipanayis A; Athanasiadis EI; Gerstung M; Bayraktar O; Cvejic A
    Nat Commun; 2024 May; 15(1):4388. PubMed ID: 38782901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
    Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric compression develops noise-driven single-cell heterogeneity.
    Zhao X; Hu J; Li Y; Guo M
    Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34916290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
    Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
    Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
    Goodwin J; Neugent ML; Lee SY; Choe JH; Choi H; Jenkins DMR; Ruthenborg RJ; Robinson MW; Jeong JY; Wake M; Abe H; Takeda N; Endo H; Inoue M; Xuan Z; Yoo H; Chen M; Ahn JM; Minna JD; Helke KL; Singh PK; Shackelford DB; Kim JW
    Nat Commun; 2017 May; 8():15503. PubMed ID: 28548087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
    Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
    Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
    Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H
    J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer.
    Jia Q; Wu W; Wang Y; Alexander PB; Sun C; Gong Z; Cheng JN; Sun H; Guan Y; Xia X; Yang L; Yi X; Wan YY; Wang H; He J; Futreal PA; Li QJ; Zhu B
    Nat Commun; 2018 Dec; 9(1):5361. PubMed ID: 30560866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary transcriptome map of non-small cell lung cancer.
    Fujii T; Dracheva T; Player A; Chacko S; Clifford R; Strausberg RL; Buetow K; Azumi N; Travis WD; Jen J
    Cancer Res; 2002 Jun; 62(12):3340-6. PubMed ID: 12067970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers.
    Lim EH; Aggarwal A; Agasthian T; Wong PS; Tan C; Sim E; Tan L; Goh PS; Wang SC; Khoo KL; Mukherjee A; Khoo SM; Chua G; Nilsson B; Lee KH; Tan P
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5980-7. PubMed ID: 14676123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the relationship between the IL-17A gene expression level and regulatory miRNA-9 in relation to tumor progression in patients with non-small cell lung cancer: a pilot study.
    Migdalska-Sęk M; Góralska K; Jabłoński S; Kordiak J; Nawrot E; Kiszałkiewicz JM; Pastuszak-Lewandoska D; Baran K; Stuss M; Brzeziańska-Lasota E
    Mol Biol Rep; 2020 Jan; 47(1):583-592. PubMed ID: 31707599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
    La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
    Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.